Health care shares are lower in mid-session trading while Xoma (XOMA) tumbles after disappointing results from a clinical trial. The company is down nearly 30% in early trading, after it said late Tuesday its Phase 2b trial of XOM
From FNNO.com, this is the Financial News Network. I’m Cleo
Stiller-Farrell and this is your Midweek Market Wrap Up. The British
Bankers’ Association, which has the supervisory role of setting the
influential Libor rates, announced that it would be willing to give up
its...
